CraigDScovilleMD

Clinical Trials

• A Study of LY3337641 in Rheumatoid Arthritis Start of enrollment: 2016 Aug 22

  Terminated

  Phase 2

• A Study of Ixekizumab (LY2439821) in bDMARD-Naive Participants With Radiographic Axial Spondyloarthritis Start of enrollment: 2016 May 02

  Completed

  Phase 3

• A Study of Ixekizumab (LY2439821) in TNF Inhibitor Experienced Participants With Radiographic Axial Spondyloarthritis Start of enrollment: 2016 Apr 12

  Completed

  Phase 3

• A Study of Ixekizumab (LY2439821) in Participants With Nonradiographic Axial Spondyloarthritis Start of enrollment: 2016 Aug 02

  Completed

  Phase 3

• A Long Term Extension Study of Ixekizumab (LY2439821) in Participants With Axial Spondyloarthritis Start of enrollment: 2017 May 09

  Completed

  Phase 3

• Efficacy and Safety of GSK3196165 Versus Placebo and Tofacitinib in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic (cs)/Biologic (b) Disease Modifying Anti-rheumatic Drugs (DMARDs) Start of enrollment: 2019 Jun 05

  Terminated

  Phase 3

• Comparing the Incidence of Preeclampsia Between Pregnant Women Receiving Tdap Vaccinations at Week 28 or at Week 36 Start of enrollment: 2020 Dec 01

  Not yet recruiting

  Phase 4

• Join now to see all